Assessing sleep habits in school-aged children with phenylketonuria: a comparative study

Ayşe Mete Yeşil1,2, Halil Tuna Akar3,4, Yılmaz Yıldız3

  • 1Division of Developmental Pediatrics, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Turkey.

PubMed

Insights

Children with phenylketonuria (PKU) show similar sleep patterns to controls, but are less likely to awaken independently. Sleep hygiene impacts HPA and control groups differently than those with PKU.

Area of Science:

  • Metabolic disorders
  • Neurodevelopmental disorders
  • Sleep science

Background:

  • Phenylketonuria (PKU) is a metabolic disorder affecting phenylalanine hydroxylase, potentially causing neurodevelopmental issues.
  • Sleep is vital for cognitive and behavioral development, yet underexplored in pediatric PKU.
  • Existing research on PKU and sleep primarily focuses on adults, with limited data on school-aged children.

Purpose of the Study:

  • To evaluate sleep characteristics in school-aged children with PKU compared to hyperphenylalaninemia (HPA) and healthy controls.
  • To identify factors influencing sleep patterns in these pediatric groups.
  • To investigate the relationship between phenylalanine levels, sleep hygiene, and sleep disturbances.

Main Methods:

  • A cohort of 101 children (aged 5-10 years) including 37 with PKU, 31 with HPA, and 33 healthy controls.
  • Sleep quality and disturbances assessed via the Children's Sleep Habits Questionnaire (CSHQ) and parent reports.
  • Analysis included phenylalanine levels and sleep hygiene practices.

Main Results:

  • No significant differences in overall CSHQ scores were found across the PKU, HPA, and control groups.
  • Children with PKU were less likely to awaken independently compared to other groups.
  • Phenylalanine levels correlated with reduced sleep anxiety, but not overall sleep characteristics.
  • Sleep hygiene influenced sleep in HPA and control groups, but not in the PKU group.

Conclusions:

  • Sleep patterns in school-aged children with PKU are largely similar to HPA and control groups, with a notable exception in self-awakening.
  • The lack of sleep hygiene influence in the PKU group suggests unique regulatory factors.
  • Further research is needed to explore biological, behavioral, and environmental determinants of sleep in PKU for targeted interventions.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...